Abstract:[Objective] Detect the levels of dendritic cell subsets in systemic lupus erythematosus (SLE) patients, and study its correlation with SLE activity criteria. [Methods] The immunofluorescence staining and flow cytometer were used to measure the expression of the myeloid dendritic cell (MDC) subsets CD11c+ and the plasmacytoid dendritic cell (PDC) subsets CD123+, and the correlations with SLEDAI, ds-DNA, C3 and C4 were analyzed. [Results] The expression of CD11c+ and CD123+ as (0.21±0.12); (0.19±0.13) in peripheral blood of SLE patients and active phase patients decreased significantly (P <0.05) compared with control groups (0.36±0.07); (0.29±0.9). There were significant differences (P <0.05) of the percents of peripheral blood CD11c+ and CD123+ between active phase SLE groups as (0.16±0.11); (0.13±0.06) or quiescent period SLE groups as (0.26±0.13); (0.23±0.16). The levels of CD11c+ and CD123+ were correlated significantly with SLEDAI and ds-DNA (with r value of -0.408, -0.436, -0.474, -0.528, and p of 0.018, 0.013, 0.009 and 0.003 respectively), but had no evident correlation with C3 and C4. [Conclusions] The results indicated that peripheral blood dendritic cell subsets decreased significantly in SLE patients, and could be used as an impersonal SLE activity index.

Correlation between levels of dendritic cell subsets in systemic lupus erythematosus patients and SLEDAI